AzTrials
AzTrials

Type2 DiabetesS4C - COVID-19NCT04738032

Stories for Change: Digital Storytelling Intervention for Diabetes Self-Management in the COVID-19 Pandemic

An observational study of Type2 Diabetes, run by Mayo Clinic at 3 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hispanic adults are twice as likely to have type 2 diabetes mellitus (T2D) and 1.5 times more likely to die from the disease than non-Hispanic whites. These disparities are mediated, in part, by less healthful levels of physical activity, dietary quality, medication adherence, and self-monitoring of blood glucose than… Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Type2 Diabetes
What is being tested?
Digital Storytelling Intervention
How many people
76 participants
Where
3 sitesUnited States
Study dates
26 Aug 2020to 7 Jan 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Self-identifies as Hispanic or Latino and has poorly controlled type 2 diabetes.

Who may be able to join

  • Self-identifies as Hispanic or Latino.
  • Between 18 and 70 years of age.
  • Participated in the parent study

Who cannot join

  • Does not self-identifies as Hispanic or Latino.
  • Is not between 18 and 70 years of age.
  • Did not participated in the parent study

Trial locations and contacts

3 sites in 1 country.

United States3 sites
  • Hennepin Healthcare

    Minneapolis, Minnesota, 55404

  • Mountain Park Health Center

    Phoenix, Arizona, 85012

  • Mayo Clinic

    Rochester, Minnesota, 55905

Other trials in United States

About this study

Hispanic adults are twice as likely to have type 2 diabetes mellitus (T2D) and 1.5 times more likely to die from the disease than non-Hispanic whites. These disparities are mediated, in part, by less healthful levels of physical activity, dietary quality, medication adherence, and self-monitoring of blood glucose than non-Hispanic whites. Innovative approaches that arise from affected communities are needed to address these health disparities.

Community-based participatory research (CBPR) has been successful in targeting health issues among Hispanic and immigrant populations; CBPR is an effective approach for addressing health behaviors in a sociocultural context. In 2004, the research team developed a CBPR partnership between immigrant communities and academic institutions called Rochester Healthy Community Partnership (RHCP)

Read more

Storytelling or narrative-based interventions are designed to incorporate culture-centric health messaging to promote behavior change among vulnerable populations. Digital storytelling interventions are narrative-based videos elicited through a CBPR approach to surface the authentic voices of individuals overcoming obstacles toward engaging in health promoting behaviors to shape positive health behaviors of viewers through influences on attitudes and beliefs.

RHCP partners from Hispanic communities identified T2D as a priority area for intervention, and have co-created each of the formative phases leading up to this proposal. Narrative theory and social cognitive theory formed the conceptual basis for intervention development. The study team conducted surveys and focus groups to derive the approach and personnel for building an authentic intervention that was created in a digital storytelling workshop where stories about diabetes self-management were captured, recorded, and edited to derive the final intervention products in video forma. The respective digital storytelling videos were pilot tested with 25 patients across healthcare institutions in Minnesota and Arizona. The intervention was rated as highly acceptable, culturally relevant, and perceived as efficacious for motivating behavioral change.

The overall objective of this project is therefore to assess the efficacy of a digital storytelling intervention derived through a CBPR approach on self-management of T2D among Hispanic adults during a pandemic.

Read the detailed description

The study team will conduct an observational trial in a virtual settings at two healthcare institutions among 80 Hispanic adults with poorly controlled T2D (hemoglobin A1c≥8%) who participated in a parent study, but were previously randomized to the Control group. The participants will view the 12-minute digital storytelling video, as well as completed a brief survey regarding how the pandemic may have affected their diabetes self-care.

Conditions
Type2 Diabetes
Being tested
Digital Storytelling Intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital Storytelling InterventionOther

    12-minute digital storytelling intervention in Spanish, with four individuals explaining their personal Type 2 Diabetes stories.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diabetes self-management behaviors

    This is a brief survey instrument to assess the following domains: general diet, specific (diabetes) diet, physical activity, diabetes medication use, and blood glucose monitoring during the pandemic.

    Measured: 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Feb 2021
  2. Study start26 Aug 2020
  3. Primary completion7 Jan 2021
  4. Study completion7 Jan 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Other
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04738032
Sponsor's protocol ID
20-006354
Acronym
S4C - COVID-19
Status last verified
Feb 2021
First submitted
2 Feb 2021
Last updated
4 Feb 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Type2 Diabetes, run by Mayo Clinic at 3 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diabetes self-management behaviors (time frame: 5 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2021; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in